See more : Kokuyo Camlin Limited (KOKUYOCMLN.NS) Income Statement Analysis – Financial Results
Complete financial analysis of InfuSystem Holdings, Inc. (INFU) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of InfuSystem Holdings, Inc., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
You may be interested
- Topaz Energy Corp. (TPZEF) Income Statement Analysis – Financial Results
- IperionX Limited (TAOFF) Income Statement Analysis – Financial Results
- Chongqing Zaisheng Technology Co., Ltd. (603601.SS) Income Statement Analysis – Financial Results
- Harmonic Drive Systems Inc. (6324.T) Income Statement Analysis – Financial Results
- Beijing Sinnet Technology Co., Ltd (300383.SZ) Income Statement Analysis – Financial Results
InfuSystem Holdings, Inc. (INFU)
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 125.79M | 109.91M | 102.38M | 97.39M | 81.12M | 67.14M | 71.08M | 70.50M | 72.13M | 66.49M | 62.28M | 58.83M | 54.64M | 47.23M | 38.96M | 35.42M | 6.58M | 0.00 | 0.00 |
| Cost of Revenue | 62.68M | 47.34M | 42.19M | 38.63M | 34.23M | 28.12M | 27.72M | 25.76M | 20.94M | 19.13M | 18.60M | 15.92M | 19.28M | 13.68M | 10.33M | 9.19M | 1.62M | 0.00 | 0.00 |
| Gross Profit | 63.11M | 62.57M | 60.20M | 58.76M | 46.88M | 39.02M | 43.36M | 44.74M | 51.18M | 47.35M | 43.68M | 42.91M | 35.36M | 33.55M | 28.64M | 26.22M | 4.96M | 0.00 | 0.00 |
| Gross Profit Ratio | 50.17% | 56.93% | 58.80% | 60.33% | 57.80% | 58.12% | 61.01% | 63.46% | 70.97% | 71.22% | 70.13% | 72.94% | 64.71% | 71.03% | 73.50% | 74.05% | 75.39% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 45.38M | 46.08M | 42.26M | 35.20M | 29.02M | 24.85M | 25.20M | 24.63M | 23.78M | 19.99M | 18.97M | 23.06M | 17.99M | 20.62M | 12.22M | 11.77M | 4.89M | 919.22B | 0.00 |
| Selling & Marketing | 12.65M | 12.26M | 10.78M | 9.66M | 9.93M | 9.11M | 9.78M | 9.66M | 10.42M | 9.75M | 9.66M | 9.86M | 9.37M | 7.09M | 5.26M | 4.66M | 649.00K | -919.20B | 0.00 |
| SG&A | 58.03M | 58.34M | 53.04M | 44.86M | 38.96M | 33.95M | 34.98M | 34.29M | 34.20M | 29.73M | 28.63M | 32.93M | 27.36M | 27.71M | 17.48M | 16.42M | 6.12M | 20.82M | 24.48K |
| Other Expenses | 990.00K | 2.58M | 4.34M | 5.08M | 4.40M | -37.00K | -113.00K | 6.00K | 13.00K | 13.00K | 301.00K | -141.00K | 6.76M | 6.77M | 5.83M | 5.01M | 6.46M | 20.82M | 0.00 |
| Operating Expenses | 59.02M | 60.92M | 57.38M | 49.93M | 43.36M | 38.60M | 46.18M | 43.77M | 42.32M | 38.02M | 37.78M | 40.91M | 34.12M | 34.48M | 23.31M | 21.44M | 6.46M | 20.82M | 24.48K |
| Cost & Expenses | 121.70M | 108.26M | 99.56M | 88.56M | 77.59M | 66.72M | 73.90M | 69.52M | 63.26M | 57.16M | 56.38M | 56.83M | 53.40M | 48.17M | 33.64M | 30.63M | 8.08M | 20.82M | 24.48K |
| Interest Income | 0.00 | 1.40M | 1.38M | 1.26M | 1.90M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 4.00K | 36.00K | 3.88M | 3.20M | 0.00 |
| Interest Expense | 2.17M | 1.40M | 1.38M | 1.26M | 1.90M | 1.42M | 1.33M | 1.34M | 1.71M | 3.13M | 3.50M | 3.34M | 2.19M | 3.35M | 3.50M | 3.77M | 774.00K | 1.30K | 300.00 |
| Depreciation & Amortization | 12.51M | 13.36M | 14.63M | 14.03M | 12.34M | 11.31M | 12.52M | 10.74M | 8.24M | 6.14M | 8.03M | 8.40M | 9.05M | 8.60M | 6.44M | 6.40M | 862.00K | 6.66M | 0.00 |
| EBITDA | 16.50M | 15.09M | 17.15M | 22.82M | 15.77M | 11.69M | 8.60M | 11.72M | 13.94M | 15.49M | 14.23M | 9.45M | -57.34M | 7.75M | 11.69M | 20.40M | -635.00K | -6.82M | -24.48K |
| EBITDA Ratio | 13.11% | 13.55% | 16.86% | 23.44% | 19.44% | 17.41% | 13.49% | 16.63% | 23.74% | 23.29% | 22.85% | 17.44% | 18.82% | 16.21% | 30.22% | 31.70% | 40.40% | 0.00% | 0.00% |
| Operating Income | 4.09M | 1.65M | 2.82M | 8.83M | 3.53M | 415.00K | -3.81M | 974.00K | 8.86M | 9.33M | 5.90M | 2.00M | -66.36M | -938.00K | 5.33M | 4.79M | -1.50M | -20.82M | -24.48K |
| Operating Income Ratio | 3.25% | 1.50% | 2.75% | 9.06% | 4.35% | 0.62% | -5.36% | 1.38% | 12.29% | 14.03% | 9.47% | 3.40% | -121.45% | -1.99% | 13.67% | 13.51% | -22.74% | 0.00% | 0.00% |
| Total Other Income/Expenses | -2.24M | -1.52M | -1.56M | -1.28M | -2.00M | -1.46M | -1.45M | -1.34M | -3.29M | -3.12M | -3.20M | -4.15M | -2.22M | -2.29M | -3.58M | 6.08M | -189.00K | -6,821.45B | 0.00 |
| Income Before Tax | 1.85M | 130.00K | 1.26M | 7.54M | 1.52M | -1.04M | -5.26M | -364.00K | 5.57M | 6.21M | 2.70M | -2.15M | -68.58M | -3.22M | 1.75M | 10.87M | -1.69M | -6.82M | 0.00 |
| Income Before Tax Ratio | 1.47% | 0.12% | 1.23% | 7.75% | 1.88% | -1.55% | -7.40% | -0.52% | 7.73% | 9.34% | 4.34% | -3.66% | -125.51% | -6.82% | 4.49% | 30.68% | -25.62% | 0.00% | 0.00% |
| Income Tax Expense | 979.00K | 112.00K | -163.00K | -9.79M | 163.00K | 53.00K | 15.45M | -142.00K | 1.83M | 2.85M | 1.03M | -663.00K | -23.13M | -1.37M | 977.00K | 907.00K | 1.11M | 1.04M | 24.78K |
| Net Income | 872.00K | 18.00K | 1.42M | 17.33M | 1.36M | -1.10M | -20.71M | -222.00K | 3.74M | 3.36M | 1.67M | -1.49M | -45.44M | -1.85M | 774.00K | 9.96M | -2.80M | -7.86M | -24.78K |
| Net Income Ratio | 0.69% | 0.02% | 1.39% | 17.80% | 1.68% | -1.63% | -29.13% | -0.31% | 5.19% | 5.05% | 2.68% | -2.53% | -83.17% | -3.92% | 1.99% | 28.12% | -42.48% | 0.00% | 0.00% |
| EPS | 0.04 | 0.00 | 0.07 | 0.86 | 0.07 | -0.05 | -0.91 | -0.01 | 0.17 | 0.15 | 0.08 | -0.07 | -2.16 | -0.09 | 0.04 | 0.56 | -0.15 | -0.58 | -0.01 |
| EPS Diluted | 0.04 | 0.00 | 0.06 | 0.80 | 0.07 | -0.05 | -0.91 | -0.01 | 0.16 | 0.15 | 0.08 | -0.07 | -2.16 | -0.09 | 0.04 | 0.53 | -0.15 | -0.58 | -0.01 |
| Weighted Avg Shares Out | 21.02M | 20.65M | 20.52M | 20.11M | 19.73M | 21.42M | 22.74M | 22.20M | 22.41M | 22.15M | 21.87M | 21.27M | 21.07M | 19.72M | 18.61M | 17.94M | 18.30M | 13.66M | 3.25M |
| Weighted Avg Shares Out (Dil) | 21.65M | 21.55M | 22.05M | 21.72M | 20.84M | 21.42M | 22.74M | 22.62M | 22.84M | 22.55M | 22.07M | 21.43M | 21.07M | 19.72M | 18.93M | 18.67M | 18.30M | 13.66M | 3.25M |
InfuSystem Holdings Inc.'s (INFU) CEO Rich Dilorio on Q4 2020 Results - Earnings Call Transcript
InfuSystem Holdings Inc.'s (INFU) CEO Rich Dilorio on Q4 2020 Results - Earnings Call Transcript
InfuSystem Reports Fourth Quarter and Full Year 2020 Financial Results
Full Year 2020 vs. Full Year 2019: Net Revenues: $97.4 million, a 20% increase Net Income: $17.3 million, a 15.9 million increase, Adjusted EBITDA: $26.2 million, a 44% increase, and Adjusted EBITDA margin of 27%, a 4.4% increase
InfuSystem to Report Fourth Quarter and Full Year 2020 Financial Results on Wednesday, March 17, 2021
Investor Conference Call to be held 9:00 a.m. Eastern Time Investor Conference Call to be held 9:00 a.m. Eastern Time
InfuSystem Announces Appointment of Carrie Lachance as President
ROCHESTER HILLS, Michigan, March 02, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced...
InfuSystem Announces New $75 Million Revolving Credit Facility
RODCHESTER HILLS, Michigan, Feb. 11, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced...
InfuSystem Acquires Biomedical Services Company to Expand DME Services Platform
Rochester Hills, Michigan, Feb. 03, 2021 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced...
A Trio of Small Caps for the Growth-Focused Investor
Growth-focused investors may be interested in the following small-cap stocks, as they represent companies whose trailing 12-month earnings per share improved significantly on a year-over-year basis.
InfuSystem: Strength In Core Businesses Hedges Against COVID-19 Headwinds
InfuSystem is uniquely positioned to benefit from any resurgence in COVID-19, and ex-COVID has strength in the core business model. Shareholders have enjoyed ~120% upside YTD, and shares have the legs to deliver more on the back of INFU's strong...
InfuSystem Holdings, Inc. Issues Full Year 2021 Guidance
Revenues of $107 million - $110 million; Adjusted EBITDA of $29 million - $30 million; Operating Cash Flow of $21 million - $23 million; Revenues of $107 million - $110 million; Adjusted EBITDA of $29 million - $30 million; Operating Cash Flow of $21...
InfuSystem to Present at 13th Annual LD Micro Main Event Tuesday, December 15, 2020
Rochester Hills, Michigan, Dec. 14, 2020 (GLOBE NEWSWIRE) -- InfuSystem Holdings, Inc. (NYSE American: INFU), (“InfuSystem” or the “Company), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today announced...
Source: https://incomestatements.info
Category: Stock Reports